Neo-peripheral adaptive immune score predicts neoadjuvant chemotherapy for locally advanced breast cancer.

Huiling WangXiaonan ShengTingting YanYaqian XuYaohui WangYanping LinJie ZhangYumei YeShuguang XuLiheng ZhouWenjin YinJinsong Lu

Published in: Breast cancer research and treatment (2022)

The neoPAI Score defined by the percentages of peripheral immune cell subsets could be used as a potential biomarker for neoadjuvant chemotherapy efficacy.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
chemotherapy induced
rectal cancer
squamous cell carcinoma
peripheral blood
radiation therapy
early stage